Warner Chilcott: Clinical Trials

11 trials sponsored by Warner Chilcott, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 3 terminated. 11 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 211Completed 8, Terminated 3

Follow Warner Chilcott: new trials by email

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy
Estradiol Vaginal Capsule (EVC), Placebo - Vulvovaginal Atrophy, Menopause
Phase 2CompletedWarner Chilcott2032016-02-152017-08-23
Assess Safety & Efficacy of WC3055 in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
WC3055, Placebo - Benign Prostatic Hyperplasia
Phase 2CompletedWarner Chilcott7962013-08-012015-06-29
Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction
WC3036-11F/Alprostadil in Vehicle 2.5%, WC3036-12F/Alprostadil in Vehicle 0.5%, WC3036-13P/Vehicle Only 0.5% - Erectile Dysfunction
Phase 2TerminatedWarner Chilcott162013-02-012014-08-12
Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure
placebo, testosterone - Heart Failure
Phase 2TerminatedWarner Chilcott172009-07-012012-01-13
Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women
150 mg, 75 mg, 100 mg - Postmenopausal Osteoporosis
Phase 2CompletedWarner Chilcott2052009-05-012015-06-29
A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity
Darifenacin - Neurogenic Detrusor Overactivity
Phase 2TerminatedWarner Chilcott352008-10-072022-06-09
Treatment of Moderate to Severe Facial Acne Vulgaris
Doxycycline 0.6 mg/kg/day, Doxycycline 1.2 mg/kg/day, Doxycycline 2.4 mg/kg/day - Acne Vulgaris
Phase 2CompletedWarner Chilcott2572008-02-012013-04-22
Asacol Acute Diverticulitis(DIVA)Study
Mesalamine, Probiotic, Placebo - Diverticulitis
Phase 2CompletedWarner Chilcott1172007-11-012013-04-22
Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate
risedronate - Postmenopausal Women
Phase 2CompletedWarner Chilcott1812006-07-012012-01-13
Study of Bleeding With Extended Administration of an Oral Contraceptive
Norethindrone 1 mg / ethinyl estradiol 20 mcg - Contraception
Phase 2CompletedWarner Chilcott2072006-06-012008-05-08
Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD
risedronate, experimental - Postmenopausal
Phase 2CompletedWarner Chilcott3702004-04-012013-04-17

Conditions studied

Acne Vulgaris (1)  ·  Diverticulitis (1)  ·  Dyspareunia (1)  ·  Erectile Dysfunction (1)  ·  Heart Failure (1)  ·  Meningomyelocele (1)  ·  Osteoporosis, Postmenopausal (1)  ·  Prostatic Hyperplasia (1)  ·  Spinal Cord Injuries (1)  ·  Urinary Bladder, Overactive (1)

Interventions

Risedronic Acid (2)  ·  Anti-Bacterial Agents (1)  ·  Doxycycline (1)  ·  Ethinyl Estradiol (1)  ·  Mesalamine (1)  ·  Norethindrone (1)  ·  Nutrition Assessment (1)  ·  Probiotics (1)  ·  Testosterone (1)  ·  darifenacin (1)

Countries

United States (11)  ·  Canada (1)  ·  Colombia (1)  ·  Croatia (1)  ·  Netherlands (1)  ·  Poland (1)

Top investigators

Herman Ellman, MD (3)  ·  Vilma Sniukiene, MD (2)  ·  Ana Balske, MD, PhD (1)  ·  Angelo Secci, MD (1)  ·  Chantell Wilson, PhD (1)  ·  John Beary, MD (1)  ·  Jose Brum, MD (1)  ·  Lu A Sun, MD, PhD (1)

Results publications

PMID 23426454